Objective
Periodontal disease resolution was hypothesized to impact systemic HIV measures.
Methods
In this longitudinal cohort study, 73 HIV-positive subjects received comprehensive dental care. AAP, CDC/AAP and biofilm gingival interface case definitions determined periodontal classification. In a subset, IL-6 was measured. Multivariable binary logistic regression models estimated odds of periodontitis development for comparisons between HIV and NHANES (2009–12) groups.
Results
In both groups, moderate/severe periodontitis was positively associated with non-white race, smoking, male gender, low income and increased pro-inflammatory cytokines. Likelihood of HIV periodontitis was higher across demographic variables. Subjects with severe periodontitis on antiretroviral therapy demonstrated high plasma viral loads at baseline (median= 464 co/ml; mean 65,773 co/ml). Post intervention, HIV periodontitis distribution became similar to NHANES and IL-6 levels decreased 2-fold (p=0.07). Subjects with suppressed viral load at baseline demonstrated increased CD4 counts at 12 months post intervention (P=0.027) (n=26).
Conclusions
Smoking, being non-white and low income were associated with periodontitis in HIV and NHANES. Higher Il-6, higher HIV VL and lower CD4 were associated with moderate/severe periodontal disease. Periodontitis decreased significantly with treatment producing periodontal profiles mirroring the national norm. In a subset of suppressed subjects, decreased oral inflammation, and associated microbial translocation, yielded improved CD4 counts.